baber/WOPTO huggingface dataset:
Patent NZ-566068-A (NZ)
Title: Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
Inventor: RAY NICHOLAS CHARLES
IPC: A61K31/221
Filed: 2006-08-08
Abstract: Disclosed is a bicyclo[2.2.1]hept-7-ylamine derivative of formula (I), wherein A is -O- or -N(R12)- and the other substituents are as defined in the specification. Also discloses is the use of the compound for treating a disease or condition in which M3 muscarinic receptor activity is implicated, such as a respiratory-tract disorder, a gastrointestinal-tract disorder, a cardiovascular disorder, chronic obstructive lung disease, chronic bronchitis, asthma, chronic respiratory obstruction, bronchial hyperactivity, pulmonary fibrosis, pulmonary emphysema, allergic rhinitis, irritable bowel syndrome, spasmodic colitis, gastroduodenal ulcers, gastrointestinal convulsions or hyperanakinesia, diverticulitis, pain accompanying spasms of gastrointestinal smooth musculature, urinary-tract disorders accompanying micturition disorders including neurogenic pollakiuria, neurogenic bladder, nocturnal enuresis, psychosomatic bladder, incontinence associated with bladder spasms or chronic cystitis, urinary urgency or pollakiuria, motion sickness, or cardiovascular disorders such as vagally induced sinus bradycardia.
Patent NZ-567315-A (NZ)
Title: Peri condensed tricyclic compounds useful as antibacterial agents
Inventor: KUSALAKUMARI SUKUMAR SENTHIL KUMAR
IPC: A61K31/436
Filed: 2006-10-17
Abstract: Disclosed are tricyclic nitrogen containing compounds of formula (I), or pharmaceutically acceptable salts or solvates thereof, wherein the substituents are disclosed within the specification. The use of the compounds of formula (I) for the manufacture of a medicament for treating bacterial infection is also disclosed. Also disclosed is 6,7-Dihydro[1,4]dioxino[2,3-c]pyridazine-3-carbaldehyde, an intermediate of the compound of formula (I).
Patent NZ-569325-A (NZ)
Title: Ultra wideband communication system and method
Inventor: BREMNER DUNCAN
IPC: H04B1/69
Filed: 2006-12-20
Abstract: A method of transmitting a data file between a communication device and a portable device in a wireless ultra-wideband communication system using multi-band orthogonal frequency division multiplexing is disclosed. The method comprises: concatenating two or more frequency bands; transmitting data via the two or more concatenated frequency bands to the portable device; and providing means for positioning the portable device in a predetermined positional relationship to the communication device during the data transfer operation.
Patent NZ-579850-A (NZ)
Title: Cartilage intermediate layer protein 2 c1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
Inventor: SAXNE TORE
IPC: C07K16/18
Filed: 2008-03-27
Abstract: Disclosed is a method for differentiation of osteoarthritis from rheumatoid arthritis and nondisease conditions in a sample, comprising measuring in the sample the concentration of cartilage intermediate layer protein 2 C1 comprising SEQ ID NO: 1. Further disclosed is a peptide consisting of SEQ ID NO: 1 when used to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions, provided that the use is not performed in a human.
Patent NZ-582994-A (NZ)
Title: Wave power generation device with a buoy attached to a pair of vertical guide shafts by rollers
Inventor: YE XUEFENG
IPC: F03B13/16
Filed: 2008-07-03
Abstract: A wave power generation apparatus is disclosed. The design consists of a line of buoys (1) and a scaffold on which buoys, guiding tracks (2) and rotating shafts (3) are installed. The buoys move up/down with the movement of the waves along the guiding tracks which drives the rotation of the rotating shafts which comprise a long shaft (7) that rotates continuously to provide a stable output torque.
Patent NZ-588129-A (NZ)
Title: Continuous process for converting natural gas to liquid hydrocarbons
Inventor: GADEWAR SAGAR B
IPC: C07C1/26
Filed: 2007-02-05
Abstract: Disclosed is a method comprising providing a halogen stream, providing a first alkane stream reacting at least a portion of the halogen stream with at least a portion of the first alkane stream to form a halogenated stream, wherein the halogenated stream comprises alkyl monohalides, alkyl polyhalides, and a hydrogen halide, providing a second alkane stream and reacting at least a portion of the second alkane stream with at least a portion of the alkyl polyhalides to create at least some additional alkyl monohalides.
Patent NZ-589326-A (NZ)
Title: Anionic and nonionic aliphatic ethoxylated surfactant-based liquid detergent
Inventor: TOUSSAINT CHRISTINE
IPC: C11D3/37
Filed: 2009-05-26
Abstract: The disclosure relates to surfactant-based all-purpose cleaners useful for cleaning surfaces including household hard surfaces as well as glass, wherein the composition is a non-emulsion cleaning composition comprising: (i) 0.1% to 5% of a C10-C14 linear alkyl sulfonate surfactant; (ii) 0.1% to 5% of a non-ionic C9-C11 aliphatic ethoxylated surfactant; (iii) 0.1 to 5 % of ethanol; (iv) 0.01% to 2% of a maleic acid/olefin copolymer sodium salt; and(v) optional ingredients. The disclosed cleaning compositions are effective in removing soils such as grease soil and in leaving un-rinsed or unwiped surfaces residue free.
Patent NZ-597218-A (NZ)
Title: Circular bar-code for drug container
Inventor: RUPP PAUL
IPC: G06V30/224
Filed: 2010-06-28
Abstract: A drug container comprising a circular bar-code 1 for encoding information regarding at least one of the drug container 2 or a content of the drug container, where the drug container is a cartridge mountable in an injection device, and comprises a cylindrical main body 2. The bar-code 1 encircles a central point 14 and the bar-code 1 is configured such that the information encoded by the bar-code 1 is readable along a closed line 15 encircling the central point 14. The drug container has a front face and the bar-code 1 is located at the front face of the drug container such that the information encoded by the bar-code 1 is readable from a front view to the drug container.
Patent NZ-597573-A (NZ)
Title: Combretastatins for prevention of posterior capsule opacification
Inventor: QUINLAN ROY
IPC: C07F9/02
Filed: 2010-07-02
Abstract: 597573 Disclosed herein is the use of a combretastatin, such as combretastatin A-4 (CA4P) or a phosphate prodrug thereof, in the treatment or prevention of posterior capsule opacification. In one embodiment the combretastatin is compound of formula II.
Patent NZ-598244-A (NZ)
Title: Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry
Inventor: MEDASANI MUNISEKHAR
IPC: A23L33/00
Filed: 2010-08-11
Abstract: Disclosed is the use use of an extract in the prevention, elimination, treatment and management of infections and diseases caused by virus, fungi, bacteria, and protozoa in a human and animal subject, said extract comprising the lipophilic constituents of the Scrophulariaceae family of plants, the major said lipophilic constituent therein being one or more of the terpenes and fatty acids of said family of plants. Further disclosed is a process of extraction for the plant matter from one or more plants of the Scrophulariaceae family of plants comprising the steps of obtaining the plant matter to be extracted; subjecting the said plant matter to a preparatory operation as required such as cutting, chopping, blanching, drying, crushing, grinding, sieving or others; contacting the plant matter from the preparatory step with a pre-determined non-aqueous solvent, series of solvents, or a solvent mixture, that preferentially extracts the lipophillic components in the plant matter at pre-determined temperature and for a pre-determined duration of time in one or more extraction operations arranged in series, or parallel or a hybrid arrangement, separation of the extract solution from the plant matter in process by any of the known means; separating the solvent from the extract solution by any of the known means such as evaporation of the solvent to yield either a concentrated extract solution, or a solid form, product, said process optionally including any one or more of known processing operations such as, for example, decantation, filtration and others.
Patent NZ-601961-A (NZ)
Title: Method of treating a wellbore having annular isolation system
Inventor: GUPTA D V SATYANARAYANA
IPC: E21B33/13
Filed: 2011-03-07
Abstract: A well treatment fluid containing a borated galactomannan gum such as guam is used to isolate a productive zone in a well having multiple productive zones. The fluid (27) is particularly useful in treatment of well bores containing a mechanical zonal isolation system (30) in the productive zone of interest. The fluid is pumped into the well in a substantially non-hydrated form. The well treatment fluid is therefore highly effective in preferentially sealing or blocking productive zones in the formation since delayed hydration of the fluid may be controlled for up to several hours. The isolated zones can then be treated by perforation and hydraulic fracturing to improve the production of the well.
Patent NZ-611324-A (NZ)
Title: Il-17 binding proteins
Inventor: ZHONG SUJU
IPC: A61K39/395
Filed: 2010-03-05
Abstract: A binding protein capable of binding human IL-17 and TNF-a comprising first and second polypeptide chains, wherein the first polypeptide chain comprises a first VD1- (X1)n-VD2-C-(X2)n, wherein VD1 is a first heavy chain variable domain; VD2 is a second heavy chain variable domain; C is a heavy chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 is an Fc region; n is 0 or 1; and wherein the second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n, wherein VD1 is a first light chain variable domain; VD2 is a second light chain variable domain; C is a light chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 does not comprise an Fc region; n is 0 or 1; and wherein, in the first polypeptide chain, the VD1 or VD2 heavy chain variable domains comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 565, 670, 720, 740, 845, and 875; and wherein, in the second polypeptide chain, the VD1 or VD2 light chain variable domains comprise an amino acid sequence selected from the group consisting of SEQ ID NOs: 570, 675, 725, 745, 850, and 880.
Patent NZ-618917-A (NZ)
Title: Wear assembly
Inventor: CARPENTER CHRISTOPHER M
IPC: E02F9/28
Filed: 2007-03-28
Abstract: 618917 A wear member for attachment to excavating equipment comprising a front end, a rear end to mount to a base fixed to the excavating equipment, and a lock (17) movable between a hold position where the lock secures the wear member to the base and a release position where the wear member can be released from the base, the lock including a latch formation (115) to retain the lock in the hold and release positions. The lock remains secured to the wear member in the release position irrespective of whether the wear member is mounted to the base or the orientation of the wear member.
Patent NZ-630026-A (NZ)
Title: Inhibition of the glycine cleavage system for treatment of cancer
Inventor: DOHOON KIM
IPC: G01N33/573
Filed: 2013-02-11
Abstract: Provided is the use of glycine cleavage system (GCS) inhibitors, such as cysteamine, a RNAi agent or a relevant antibody, in the manufacture of a medicament for the treatment of serine hydroxymethyltransferase 2 (SHMT2) overexpressing tumours or tumour cells. Further provided is an in vitro method for assessing the sensitivity of tumours or tumour cells to a GCS inhibitor by measuring the level of SHMT2 expression in the tumours or tumour cells, and an in vitro method of screening candidate anti-tumour agents by contacting SHMT2 overexpressing tumours or tumour cells with the agent and determining whether the proliferation of the tumours or tumour cells is inhibited.
Patent NZ-631120-A (NZ)
Title: Photoactivatable oxygen-evolving compositions and methods for teeth whitening
Inventor: PIERGALLINI REMIGIO
IPC: A61Q11/00
Filed: 2011-04-29
Abstract: Disclosed herein is a tooth whitening composition-comprising: a peroxide present in an amount of between 1 % and 70% by weight; and Eosin Y; wherein the composition does not include a carbomer. Also disclosed is a method for whitening a tooth, the method comprising: applying to at least one tooth a composition comprising: a peroxide present in an amount of between 1 % and 70% by weight, and Eosin Y, wherein the composition does not include a cm’bomer; and exposing the composition to actinic light for less than 20 minutes, preferably for less than 20 seconds per tooth.
Patent NZ-704163-A (NZ)
Title: Vehicle identification means
Inventor: BEENKEN BJÖRN
IPC: H01Q19/06
Filed: 2013-07-22
Abstract: The invention relates to vehicle identification means (10) which comprise an at least partially electrically conductive film, a hologram (36) and/or a reflection film. Said identification means also comprises at least one contactless readable data carrier (26) comprising an antenna. According to the invention, the hologram (36) is designed as an antenna for the data carrier (26). A separate antenna is therefor no longer necessary. Also, said means can comprise several antennas in parallel.
Patent NZ-707200-A (NZ)
Title: Hybrid light chain mice
Inventor: MACDONALD LYNN
IPC: C12N15/85
Filed: 2011-06-22
Abstract: Disclosed is a method for cloning a λ (lambda) light chain variable region nucleic acid sequence, comprising the steps of: (a) obtaining a cell from a mouse comprising a Vλ gene segment and a Jλ gene segment contiguous with a mouse immunoglobulin κ light chain constant region nucleic acid sequence; and (b) cloning from the cell a λ light chain variable region nucleic acid sequence derived from the Vλ gene segment and the Jλ gene segment.
Patent NZ-708255-A (NZ)
Title: Substituted phthalazin-1 (2h)-one derivatives as selective inhibitors of poly (adp-ribose) polymerase-1
Inventor: DESAI RANJIT C
IPC: C07D513/04
Filed: 2013-12-23
Abstract: The present invention relates to compounds of general formula (I), their stereoisomers, regioisomers, tautomeric forms and intermediates involved in their synthesis, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to a process of preparing compounds of general formula (I), their stereoisomers, regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, pharmaceutical compositions containing them, and intermediates involved in their synthesis. The compounds of formula (I) are useful as PARP-1 inhibitors for the treatment of, e.g. cancer.
Patent NZ-712683-A (NZ)
Title: Attachment element
Inventor: BRUCKBAUER WOLFGANG
IPC: F16B13/04
Filed: 2014-04-28
Abstract: In an attachment element (1) for fixing an object (10) to a wall (4), wherein a shaft (2) of the attachment element (1) can be introduced into a hole (3) in the wall (4) and can be fixed to the inner surface of the hole (3), wherein the object (10) can be fixed to a holder (9) which is situated outside the hole (3) and can be connected to the shaft, it is provided that the shaft (2) has a substantially plate-like design and is formed, towards the interior of the hole, with two projections (5) oriented oppositely to one another which project from the shaft (2) counter to the direction of insertion (6) of the shaft (2) into the hole (3), are prestressed in the direction of the inner surface of the hole (3) and of which the projecting lengths, prior to insertion into the hole (3), exceed a clear width (d) of the inner surface of the hole (3), with the result that simple and secure fixing can be achieved, in particular, by wedging the projections (5) in the hole (3).
Patent NZ-713504-A (NZ)
Title: Carton with article protection feature
Inventor: HOLLEY JOHN MURDICK
IPC: B65D81/05
Filed: 2014-05-12
Abstract: The present invention relates to a carton for containing at least one article. The carton comprises at least one panel at least partially forming an interior of the carton and at least one article protection flap for protecting the at least one article. The at least one article protection flap being foldably connected to the at least one panel along a lateral fold line and moveable between a first position that is substantially parallel to the at least one panel and a second position wherein the at least one article protection flap is folded relative to the at least one panel. The at least one article protection flap comprises a longitudinal crease, a first corner spaced apart from the longitudinal crease by a first distance, and a second corner spaced apart from the longitudinal crease by a second distance, the second distance being greater than the first distance.
Patent NZ-716322-A (NZ)
Title: Method and liquid compound that improves the efficiency of ammoniacal nitrogenated fertilisers and the ammonium present in the ground
Inventor: TIRONI GALLARDO NICOLÁS IVÁN
IPC: C05G3/90
Filed: 2013-12-24
Abstract: The invention relates to a method for producing a liquid compound and to the compound used to improve the results of the application of ammoniacal nitrogenated fertilisers to crops requiring same and the ammonium present in the ground, said compound being a mixture consisting mainly of 3.5 DMPP as a nitrification inhibitor, phosphorus, the main function of which is to participate in all of the processes and energetic reactions of the crop, and amino acids which are synthesised by the plants in enzymatic reactions generated by means of the amination, where absorbed ammonium salts and organic acids are produced.
Patent NZ-721725-A (NZ)
Title: Method and system for performing a financial transaction over a communications network
Inventor: O’sullivan Marcia Christine
IPC: G06Q40/00
Filed: 2003-05-13
Abstract: A method and a system for performing a financial transaction between at least two users of a transaction system over a communications network are disclosed. The method comprises receiving at the transaction system, at least one identifier for a first user who is to receive funds; receiving at the transaction system, at least one identifier for a second user who is to transfer funds to the first user; receiving at the transaction system a financial account identifier for the second user with the financial account identifier comprising at least five characters; transmitting the financial account identifier provided for the second user from the transaction system to a nominated financial institution of the second user; and receiving at the transaction system a communication from the financial institution allowing or denying the transaction
Patent NZ-729203-A (NZ)
Title: Automatically releasable hose reel assembly
Inventor: MORGAN SEAN
IPC: F16M11/00
Filed: 2015-07-30
Abstract: A reel assembly (10) having a spool (20) comprising a drum core (22) and side disc flanges (24) attached to the drum core (22) for retaining a wound hose (26) on the spool (20), and a release mechanism (120) operatively engaging the spool (20) via a drive shaft (110). The release mechanism (120) has a pair of rotatable hubs (132, 134) arranged in axial alignment and having a clamping spring (136) fitted around the rotatable hubs (132, 134) and arranged to clamp the hubs (132, 134) together in fixed rotational relation, wherein the clamping spring (136) opens to releases the rotatable hubs (132, 134) when the spool (20) is rotated in a payout direction so that the rotatable hubs (132, 134) disengage and the spool (20) can freewheel. Whilst it might be considered desirable to have almost no resistance on payout, a small amount of frictional resistance avoids unchecked payout. The release mechanism allows a small amount of resistance to aid in efficient operation for the end user.
Patent NZ-730827-A (NZ)
Title: Improved method of manufacturing buprenorphine and analogues thereof from oripavine
Inventor: DR WEBER BEAT THEODOR
IPC: C07D489/12
Filed: 2015-10-13
Abstract: The invention relates to an improved method of preparing buprenorphine, a salt thereof, analogues of buprenorphine and their salts. In particular, the invention relates to a method of preparing buprenorphine and related products and salts in economic and ecologic ways having increased yields. The buprenorphine and analogues are produced by the reaction of formula (I) to produce formula (II) as shown in the abstract figure, wherein the formation of the tertiary alkyl alcohol at position 7 is carried out using essentially tert-butylmethylether, 2-methyl-tetrahydrofuran, dimethoxymethane or mixtures thereof.
Patent NZ-732089-A (NZ)
Title: Antimicrobial copper compositions and their use in treatment of foodstuffs and surfaces
Inventor: DAUTREUIL FRANCIS
IPC: A01N25/02
Filed: 2015-11-25
Abstract: The present disclosure provides compositions for antimicrobial use comprising: a mineral acid buffered by a buffering salt, wherein the mineral acid is sulfuric acid, wherein the buffering salt is ammonium sulfate; about 35 ppm to about 40 ppm of a copper(II) salt; and between 0.01 weight percent and 0.3 weight percent of a detergent consisting of an alkyl polyglycoside, based on the weight of the composition; wherein the composition is an aqueous solution with a pH between 1.6 and 3.5.
Patent NZ-749619-A (NZ)
Title: Tanker safety device
Inventor: SCOTT FREER
IPC: G08B21/18
Filed: 2013-02-21
Abstract: A dairy tanker safety apparatus is disclosed. The dairy tanker safety apparatus comprises monitoring means which monitors one or more sensors and an output means for providing a user of the dairy tanker with an output of the monitoring means. The at least one of the one or more sensors is a proximity sensor associated with a closure device present on an opening of a cleaning in place connection point of the dairy tank of the dairy tanker.
Patent NZ-750556-A (NZ)
Title: Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
Inventor: GUILD BRAYDON
IPC: C07H21/02
Filed: 2010-11-30
Abstract: Disclosed is a composition for modulating the expression of a protein in a target cell, wherein said composition comprises at least one RNA molecule and a transfer vehicle.
Patent NZ-757210-A (NZ)
Title: Oil-based adjuvants
Inventor: DOMINOWSKI PAUL
IPC: A61K9/107
Filed: 2014-09-19
Abstract: The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals. In a specific embodiment the invention is a method of generating antibodies as reagents or for therapeutic use, the method comprising: administering to a source animal a vaccine composition comprising an antigen against which said antibodies are desired and an adjuvant comprising an oily phase present in the amount of at least 36% v/v of said vaccine composition, a P-class CpG immunostimulatory oligonucleotide and DEAE Dextran, and wherein further said vaccine composition is a water-in-oil emulsion; harvesting a source of said antibodies from a non-human source animal and isolating said antibodies from said source.